In addition to treating multiple myeloma, Swedish also offers special supportive care treatments to improve complications associated with the cancer.

Multiple myeloma

Multiple myeloma is a cancer of plasma cells – the special white blood cells that are part of the body’s immune system and produce antibodies to fight infections. Patients with multiple myeloma have increased numbers of abnormal plasma cells that infiltrate the bone marrow and may cause decreased bone marrow blood cell production, fragile bones, pain, abnormal kidney function and decreased quantities of normal antibodies. Learn more about multiple myeloma.

Treatments

A number of treatment options are aimed at eliminating the disease to reach a state of complete remission. Swedish offers a full range of state-of-the-art treatments including:

If your physician believes you are a good candidate to participate in a clinical trial evaluating a new treatment or more effective combinations of treatments — and you agree — you will have access to the very latest in research treatments.

At any given time, the Swedish Cancer Institute offers patients more than 140 clinical-research studies involving most types of cancers. Additionally, our physician specialists collaborate with other regional and national research groups, including Southwest Oncology Group, National Cancer Institute, Puget Sound Oncology Consortium and Fred Hutchinson Cancer Research Center.

Education and support for patients and families

Beyond physical health, the Swedish Cancer Institute is committed to the emotional well-being of our patients and their families. We offer: